Furthermore, Zhang et al. found that ATF4-mediated expression of phosphoglycerate dehydrogenase enhances glycolysis in tumor-associated endothelial cells, resulting in endothelial cell overgrowth and ultimately promoting glioblastoma resistance to immunotherapy [33]. The gene discussed is ATF4; the disease is neoplasm.